Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 2,089 | 1,376 | 11,463 | 0 | 0 |
| Cost of Goods | 663 | 1,945 | 1,000 | 0 | N/A |
| Gross Profit | 1,426 | -569 | 10,463 | N/A | N/A |
| Operating Expenses | 5,864 | 4,786 | 7,229 | 7,792 | 11,369 |
| Operating Income | -3,775 | -4,410 | 3,234 | -7,792 | -11,369 |
| Interest Expense | 1,831 | 1,864 | 1,579 | 1,537 | 1,534 |
| Other Income | -148 | 229 | 1,411 | 63 | 604 |
| Pre-tax Income | -5,754 | -6,045 | 3,066 | -9,266 | -12,299 |
| Income Tax | N/A | -8 | 3 | -9 | -8 |
| Net Income Continuous | -5,754 | -6,037 | 3,063 | -9,257 | -12,291 |
| Net Income | $-5,754 | $-6,037 | $3,063 | $-9,257 | $-12,291 |
| EPS Basic Total Ops | -1.92 | -2.03 | 1.44 | -5.28 | -7.36 |
| EPS Basic Continuous Ops | -1.91 | -2.28 | 1.63 | -5.22 | -7.36 |
| EPS Diluted Total Ops | -1.92 | -1.55 | 0.96 | -5.28 | -7.36 |
| EPS Diluted Continuous Ops | -1.91 | -2.20 | 1.55 | -5.22 | -7.36 |
| EBITDA(a) | $-3,132 | $-3,660 | $3,681 | $-7,412 | $-10,986 |